European

Scotiabank and BNP Paribas launch structured products on MSCI Food Revolution and Ageing Society Indexes

Retrieved on: 
Tuesday, August 9, 2022 - 3:00pm
Banking, Professional Services, Finance, Food technology, BNP Paribas, New York Stock Exchange, SME, Corporate social responsibility, NYSE, Quanto, Growth, TSX, Toronto Stock Exchange, Group, BNS, Recreation, European, Food, Corporation, Institutional Protection Service, Scotiabank, VP, Health, Solution, Zoonosis, Agriculture, Renewable energy, Financial services, MSCI

Scotiabank announced the launch of Quanto MXN-denominated structured notes linked to MSCI Food Revolution and Ageing Society Indexes.

Key Points: 
  • Scotiabank announced the launch of Quanto MXN-denominated structured notes linked to MSCI Food Revolution and Ageing Society Indexes.
  • The offerings mark the first-ever launch in Latin America of structured products linked to custom MSCI indexes, bringing innovation and diversification into the Mexican market.
  • With growing client appetite towards volatility control strategies, BNP Paribas and Scotiabank are providing these Quantitative Investment Strategies in Mexico.
  • Our thematic indexes cover a broad range of mega-trend themes, including ageing society and food revolution.

D-Orbit Announces Multi-Year Launch and Deployment Contract with Swiss Satellite Internet of things (IoT) network operator Astrocast

Retrieved on: 
Tuesday, August 9, 2022 - 2:00pm
U.S. Securities and Exchange Commission, Risk, Ministry of Agriculture, Livestock and Fisheries (Tanzania), CEO, GLOBE, Form, Failure, IOT, SEC, 100,000, ALL, Security (finance), Annual report, Communication, OTV, Securities Act of 1933, Orbit, Environment, Entrepreneurship, Thuraya, Ebro, CCO, Industry, Phrase, Technology, SSO, Nasdaq, Partnership, Falcon 9, Agriculture, THE, Internet, XV, Growth, Prospectus, Attention, COVID-19, Acquisition, New Space, FINO, Airbus, Solution, Time, Spacecraft, ESA, Organization, Grand duchy, XXV, Suite, 6U, NASDAQ, Ownership, Adoption, Renewable energy, Communications satellite, Cryptocurrency, Molecular orbital, European, Holding company

Astrocasts existing low latency nanosatellite IoT network offers customers bidirectional communication between their devices and the companys global network.

Key Points: 
  • Astrocasts existing low latency nanosatellite IoT network offers customers bidirectional communication between their devices and the companys global network.
  • As they continue to scale, with these launches Astrocast is investing in their network to carry on providing organizations with a high-quality and reliable SatIoT experience.
  • This investment prepares Astrocast for the future and builds further robustness, reliability and resilience into customers network.
  • We are looking forward to the launch on Falcon-9 and potential future missions on European rockets, said Fabien Jordan, CEO and Co-Founder, Astrocast.

Europe Idiopathic Pulmonary Fibrosis Market Report 2022: Shifting Lifestyle Patterns, Rising Nicotine Product Usage, and Growing Health Awareness Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 9, 2022 - 2:09pm
General Health, Pharmaceutical, Health, Online, Hospital, NCBI, Ageing, Risk, Exercise, Country, Ventilation, United Kingdom, IPF, Growth, National Center for Biotechnology Information, Smoking, National Centre for Infectious Diseases, National, Prevalence, Research, Fibrosis, Patient, Degenerative disease, Nicotine, Incidence, Organization, Distribution, Disease, Person, Health insurance, European, EU

Factors such as shifting lifestyle patterns, rising nicotine product usage, and growing health awareness among the general public about efficient IPF management measures are directly proportional to the growth of the overall industry.

Key Points: 
  • Factors such as shifting lifestyle patterns, rising nicotine product usage, and growing health awareness among the general public about efficient IPF management measures are directly proportional to the growth of the overall industry.
  • Lung transplants, mechanical ventilation, oxygen therapy, and pulmonary rehabilitation are the most common non-pharmacological treatments.
  • In general, the treatment strategy for IPF is mostly determined by the patient's symptoms, illness stage, and overall health.
  • According to the European Pulmonary Fibrosis Patient Charter, around 80,000 to 111,000 persons in Europe suffer from IPF, with 30,000 to 35,000 patients diagnosed each year.

Designated Person Notification

Retrieved on: 
Tuesday, August 9, 2022 - 11:04am
Share repurchase, Electricity, FSC, Luxembourg Stock Exchange, EUR, Biomass, Treasury, OAM, Aperam, Recycling, Electrical steel, European, Company, European Parliament, News, Contact, Council, Robert Knox (private equity investor), ELG, Security (finance), EU

Luxembourg, 9 August 2022 (12:00 CET) - With reference to Article 19(3) of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulations), Aperam announces that a notification of share transactions by a Designated Person (i.e.

Key Points: 
  • Luxembourg, 9 August 2022 (12:00 CET) - With reference to Article 19(3) of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulations), Aperam announces that a notification of share transactions by a Designated Person (i.e.
  • Further details on the share buyback program are available on www.aperam.com under Investors > Equity Investors > Share Buyback.
  • Aperam is a global player in stainless, electrical and specialty steel, with customers in over 40 countries.
  • The business is organised in four primary reportable segments: Stainless & Electrical Steel, Services & Solutions, Alloys & Specialties, and Recycling.

Global Top 7 Military Transport Aircraft Programs Report 2022: Program Fact Files, Comparative SWOT Analysis, Strategy Focus, Key Trends & Growth Opportunities - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 9, 2022 - 9:12am
Defense, Air, Transport, Aerospace, Manufacturing, Other Defense, Aircraft, Embraer, NATO, Cold War, MEDEVAC, FMTC, Philippine Air Force, Special operations, Electronic warfare, EUR, Military transport aircraft, Kawasaki, Lockheed Martin C-130J Super Hercules, Comparative, Transall C-160, Lockheed Martin, Lockheed C-130 Hercules, Bird, COVID-19, Toy Soldiers Parachute Drop, Program, Air force, APAC, Airlift, Taliban, World, Embraer C-390 Millennium, SAR, Present value of growth opportunities, Airline, Weapon, Transport, Air cargo, ISR, European, EU

The "Global Top 7 Military Transport Aircraft Programs - Comparative SWOT & Program Dossier - 2022 - Program Fact Files, Comparative SWOT Analysis, Strategy Focus across Programs, Key Trends & Growth Opportunities and Market Outlook for Military Transport Aircrafts" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Top 7 Military Transport Aircraft Programs - Comparative SWOT & Program Dossier - 2022 - Program Fact Files, Comparative SWOT Analysis, Strategy Focus across Programs, Key Trends & Growth Opportunities and Market Outlook for Military Transport Aircrafts" report has been added to ResearchAndMarkets.com's offering.
  • The global defense spending reached the record high level of $2.1 trillion for 2021 while registering a 7% year-on-year growth.
  • The rise of China & its military bullying in the Asia Pacific region and the ongoing Russian invasion of Ukraine have collectively led to significant turbulence and a subsequent, massive surge in defense spending across APAC & Europe which is likely to be sustained at least for over a decade.
  • Japan has gone for the indigenous Kawasaki C-2 to meet the country's specific requirements.

Abionic Receives IVDR Certification for Its Predictive Ultra-Rapid Sepsis Test Allowing the Management of Antibiotic Administration

Retrieved on: 
Tuesday, August 9, 2022 - 5:00am
Technology, Medical Supplies, Infectious Diseases, FDA, Nanotechnology, Clinical Trials, Biotechnology, Other Health, Health, FDA, FIVE, Multimedia, Union, World Health Organization, Risk, Patient safety, Mortality, Decision-making, BSI, POC, Ecosystem, PSP, Center, Infection, IVDR, Saliva, Nature, ELISA, Environment, Urine, Compliance, Blood, Allergy, European, Patient, CDC, COVID-19, International, European Parliament, CTO, Critical care, Health, Sepsis, WHO, World, IVD, Luyt, Korea Disease Control and Prevention Agency, Immediate, Medtech, Certification, Drug, Efficiency, Medical device, Pharmaceutical industry, Abionic, EU

This certification granted by notified bodies like BSI is required for in-vitro diagnostics to continue being sold in the European Union.

Key Points: 
  • This certification granted by notified bodies like BSI is required for in-vitro diagnostics to continue being sold in the European Union.
  • The IVDRs extensive requirements were adopted by the European Parliament in 2017 and must now be implemented by May 26, 2022.
  • Abionic has been preparing for IVDR compliance since 2019, and chose BSI, a reputable notified body that was authorized to perform this certification process.
  • Two years after the commercial launch of its sepsis test, Abionics expansion is reaching a global scale.

Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results

Retrieved on: 
Monday, August 8, 2022 - 9:05pm
DREAM, FDA, U.S. Securities and Exchange Commission, Technology, Sleep, Growth, SEC, Investment, BLAST, CCC, Security (finance), OSA, CE, Patient, Company, Acceleration, Research and development, Euronext, CET, NASDAQ, General officer, Research, IDE, Goal, Total, Development, Administration, Film, Pharmaceutical industry, Renewable energy, European

Revenue was 935,000 for the second quarter ending June 30, 2022, compared to 170,000 for the second quarter ending June 30, 2021.

Key Points: 
  • Revenue was 935,000 for the second quarter ending June 30, 2022, compared to 170,000 for the second quarter ending June 30, 2021.
  • Selling, General and Administrative expenses rose to 4.5 million for the second quarter of 2022, up from 3.9 million in the second quarter of 2021.
  • Total operating loss for the second quarter and first half of 2022 was 7.4 million and 14.7 million, respectively, versus 6.3 million and 11.6 million in the second quarter and first half of 2021, respectively.
  • Nyxoah realized a net loss of 5.0 million and 11.8 million for the second quarter and first half of 2022, respectively, compared to a net loss of 6.7 million and 12.4 million for the second quarter and first half of 2021, respectively.

VBI Vaccines Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Retrieved on: 
Monday, August 8, 2022 - 1:00pm
Biotechnology, FDA, Other Health, Health, Pharmaceutical, Oncology, Other Science, Research, Infectious Diseases, Science, Clinical Trials, Shekel, FDA, Ageing, VBI, Survival, CAD, United Kingdom, Medicare, Trial of the century, CEO, R, HBV, Disease, SIF, Net, Hepatitis, Government, Patient, CDC, GBM, COVID-19, Company, Mission statement, Medicaid, Research and development, Partnership, Awareness, G&A, Fast track (FDA), GAAP, Research, Canadian government scientific research organizations, Vaccine, CPT, Israeli new shekel, Insurance, Nasdaq, Overalls, Administration, Hepatitis B, Pharmaceutical industry, Video game, Financial services, European

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced financial results for the second quarter ending June 30, 2022 and provided a corporate update.

Key Points: 
  • VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced financial results for the second quarter ending June 30, 2022 and provided a corporate update.
  • Cost of Revenue: Cost of revenues was $2.5 million in the second quarter of 2022 as compared to $2.6 million in the second quarter of 2021.
  • R&D expenses were offset by $1.0 million in the second quarter of 2022 and $3.3 million in the second quarter of 2021 by government grants and funding arrangements.
  • Foreign exchange loss for the second quarter of 2022 was $21.9 million as compared to $0.2 million for the second quarter of 2021.

Global Automotive Camera Markets Report 2022-2028: Surging Usage of ADAS & Growing Adoption of Advanced Cameras in Vehicles - ResearchAndMarkets.com

Retrieved on: 
Friday, August 5, 2022 - 11:21am
Automotive, Technology, Other Automotive, Photography, Audio, Video, Autonomous Driving, Vehicles, Continental AG, Application, Autoliv, ISP, AI, Technology, Growth, Socs, Investment, POC, ROHM, Radar, LTD, HCV genotypes, Smartphone, HD, Government, Continental, European Commission, HDR, European, COVID-19, DMS, European Parliament, Gentex, LCV, Safety, CAGR, Geography, STMicroelectronics, Council, Valeo, Automotive industry, ISO, FLIR Systems, ICS, Certification, Motor vehicle, ADAS, Adoption, Satellite navigation device, Waste management, Mobileye, Aptiv, EU

The automotive camera market is expected to grow from US$ 6,911.10 million in 2021 to US$ 30,140.14 million by 2028.

Key Points: 
  • The automotive camera market is expected to grow from US$ 6,911.10 million in 2021 to US$ 30,140.14 million by 2028.
  • Thus, such government regulations and significant investments in adopting cameras in automotive vehicles for safety and comfort are fueling the Automotive camera market growth.
  • The leading players providing the automotive cameras are significantly adopting advanced technologies addressing the trends of the automotive camera market.
  • Thus, the rising adoption of advanced cameras is bolstering the automotive camera market growth.

Siteimprove Partners with Americaneagle.com to Enable Brands to Deliver More High-Performing and Accessible Content

Retrieved on: 
Thursday, August 4, 2022 - 2:00pm
Mobile, Wireless, Networks, Internet, Professional Services, Technology, Other Communications, Other Professional Services, Public Relations, Investor Relations, Marketing, Advertising, Human Resources, Communications, W3C, SEO, International Association of Accessibility Professionals, Telerik, Internet, Accessibility, ROI, ADA, Green v. Department of Justice, Department, Compliance, European, Marketing, Fortune 500, Partnership, Connector, VP, CMS, Analytics, Computer, International Association, Internet security, E-governance, IAAP, Goal, Digital, Time, Justice, Disability, Organization, Online shopping, Book, Siteimprove

Siteimprove , the leading enterprise platform that helps brands transform content into revenue, announces its partnership with Americaneagle.com to unveil the expanded Siteimprove Connector for Sitefinity CMS, an integration that helps brands ensure their websites are accessible to everyone.

Key Points: 
  • Siteimprove , the leading enterprise platform that helps brands transform content into revenue, announces its partnership with Americaneagle.com to unveil the expanded Siteimprove Connector for Sitefinity CMS, an integration that helps brands ensure their websites are accessible to everyone.
  • In addition, cases for ADA compliance have skyrocketed in the past few years, putting added pressure on brands to deliver fully accessible websites.
  • Siteimprove is driven by the desire to help brands deliver on the promise of amazing content experiences for any outcome, said Amber Bartholomeusz, Vice President, Partner Marketing, Siteimprove.
  • Over 7,000 companies use Siteimprove to optimize their content for every outcomeand the experts have taken notice.